Feature | September 24, 2012

Updated Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities Issued by ACC, AHA, HRS

Experts recommend expanded use of cardiac resynchronization therapy in some patients, offer guidance on device follow-up

September 24, 2012 — Surgically inserted cardiac devices play an important role in treating certain heart problems. In fact, an estimated 400,000 devices, including pacemakers and cardioverter defibrillators, are implanted each year in the United States. Still, selecting patients in whom these devices will provide the most benefit can be challenging.

To help clinicians keep pace with the emerging clinical research and advances related to device-based therapies, the American College of Cardiology (ACC) Foundation, American Heart Association (AHA) and the Heart Rhythm Society (HRS) have jointly released updated guidelines for the use of devices in treating heart rhythm disorders. Chief among the updates are expanded indications for cardiac resynchronization therapy (CRT), a procedure that is used to better synchronize or coordinate the rhythm of the heart, thereby improving the way the heart functions. The revised guidelines reflect new evidence that patients with mild heart failure or NYHA class II should also be considered for CRT based on what their electrocardiogram (ECG) looks like.

“These are patients who had previously been excluded from receiving CRT, but studies have shown they can benefit from this procedure. It can really improve their lives by delaying or avoiding worsening heart failure,” said Cynthia M. Tracy, M.D., George Washington University, chair of the writing group.

Within the guidelines, the writing group clarifies and provides recommendations about which patients are most likely to benefit from CRT. “There is growing evidence that patients with the widest, most abnormal looking ECG potentially benefit most compared to patients whose ECG are less abnormal,” said Tracy. In particular, patients with wide left bundle-branch block complexes as seen on their ECG seem to do well with CRT.

“It’s very difficult on a case-by-case basis to assess a patient’s likelihood of success,” said Tracy. “Implanting a device is relatively straight forward, but it’s not completely without potential for complication, and there are a lot of management issues that come up. You want to be sure you are doing the right thing by your patient and choosing the right device for the right patient.”

By pulling together and examining the best evidence to date, she says the guidelines can provide physicians with a clear indication for who is most likely to benefit from device-based therapies. In addition, other modifications have been made to help physicians decide which patients with atrial fibrillation might benefit from CRT. In particular, some patients with weak hearts and irregular, slow heart rhythms can benefit from CRT. The committee also summarized the minimum frequency of in-person and remote monitoring of patients with cardiovascular implantable electronic devices.

The original guidelines for device therapy were issued in 2008 and became the first to combine indications for all cardiac implantable electronic devices. The writing group reviewed these earlier recommendations and, other than the new and modified recommendations for CRT, they remain unchanged and current policy for the ACCF and AHA. “The updated guidelines extend and clarify current best practices and will continue to evolve as technology advances,” Tracy said.

The writing group included experts in device therapy, cardiovascular care, internal medicine, cardiovascular surgery, and pediatric and adult electrophysiology. The guidelines were also developed in collaboration with the American Association for Thoracic Surgery, Heart Failure Society of America and Society of Thoracic Surgeons. A related appropriateness use document is currently in development that will help to further interpret the best science and apply it to various clinical scenarios.

The guidelines will be published in the Journal of the American College of CardiologyCirculation: Journal of the American Heart Association; and the Heart Rhythm Journal.

For more information: www.cardiosource.org/ACC, www.heart.org, www.hrsonline.org

Related Content

INRatio, Alere, Abbott, I and R testing, INR testing
Feature | Point of Care Testing| December 07, 2016
December 7, 2016 — Abbott has filed a complaint to terminate its proposed acquisition of Alere based on the substanti
PET, F-18 florbetaben, cardiac amyloidosis, Princess Alexandria Hospital

In a pilot study, F-18-florbetaben PET imaging appeared promising for differentiating between cardiac amyloidosis and hypertensive heart disease. Image courtesy of W. Phillip Law/Princess Alexandra Hospital, Brisbane, Australia.

News | Nuclear Imaging| December 06, 2016
Researchers at Princess Alexandra Hospital, Brisbane, Australia, have demonstrated that cardiac amyloidosis (abnormal...
TCT 2016, TCT.16, main arena, late breaking trials, transcatheter cardiovascular therapeutics

There were several hot topics that came out of the 2016 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting Oct. 29 - Nov. 2, which made this month's top 20 list, including several videos. Number 4 on the list of content was the result of the EXCEL Trial key TCT late-breaker, which showed stenting is equal in outcomes to surgery for the first time, when using one of the latest generation drug-eluting stents. 

Feature | December 05, 2016
December 5, 2016 — Here is the list of the top 20 most popular pieces of content on the Diagnostic and Interventional
coronary CT angiography, CCTA, alcohol consumption, CAD, coronary artery disease, RSNA 2016
News | CT Angiography (CTA)| November 29, 2016
Researchers using coronary computed tomography angiography (CCTA) found no association between light to moderate...
News | Cath Lab| November 21, 2016
November 21, 2016 – A single-center study sponsored by the National Institutes of Health (NHLBI) failed to show an ea
InspireMD, CGuard embolic protection system, EPS, clinical data, internal carotid artery stenosis, ICA
News | Stents Carotid| November 18, 2016
November 18, 2016 — InspireMD Inc.
Boston Scientific, HeartLogic Heart Failure Diagnostic Service, MultiSENSE trial data, AHA Scientific Sessions 2016
News | Heart Failure| November 18, 2016
Boston Scientific recently announced results from the first clinical trial evaluating the performance of the HeartLogic...
cardiac rehabilitation, depression, death risk, heart surgery, Intermountain Medical Center Heart Institute, AHA Scientific Sessions 2016
News | Cardiac Rehabilitation| November 15, 2016
Depression has been known to be associated with poor cardiovascular outcomes. But if patients who are depressed attend...
atrial fibrillation, warfarin, dementia, Intermountain Medical Center Heart Institute, American Heart Association, AHA Scientific Sessions 2016
News | Atrial Fibrillation| November 15, 2016
Atrial fibrillation patients who use warfarin to lower risk of stroke are at higher risk of developing dementia than...
Medtronic, Claria MRI Quad CRT-D SureScan, FDA approval
Technology | Cardiac Resynchronization Therapy Devices (CRT)| November 15, 2016
Medtronic plc  has received U.S. Food and Drug Administration (FDA) approval for the Claria MRI Quad Cardiac...
Overlay Init